BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 9537449)

  • 1. Transforming growth factor-β-stimulated clone-22 is a negative-feedback regulator of Ras / Raf signaling: Implications for tumorigenesis.
    Nakamura M; Kitaura J; Enomoto Y; Lu Y; Nishimura K; Isobe M; Ozaki K; Komeno Y; Nakahara F; Oki T; Kume H; Homma Y; Kitamura T
    Cancer Sci; 2012 Jan; 103(1):26-33. PubMed ID: 21943131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAS/RAFlandscape in monoclonal plasma cell conditions.
    Schavgoulidze A; Corre J; Samur MK; Mazzotti C; Pavageau L; Perrot A; Cazaubiel T; Leleu X; Macro M; Belhadj K; Roussel M; Brechignac S; Montes L; Caillot D; Frenzel L; Rey P; Schiano JM; Chalopin T; Jacquet C; Richez V; Orsini Piocelle F; Fontan J; Manier S; Martinet L; Sciambi A; Mohty M; Avet-Loiseau H
    Blood; 2024 Apr; ():. PubMed ID: 38643494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic overexpression of insulin receptor substrate 1 in hepatocytes enhances hepatocellular proliferation in young mice only.
    Mohr L; Banerjee K; Kleinschmidt M; Bartolomé Rodríguez MM; Wands JR
    Hepatol Res; 2008 Dec; 38(12):1233-40. PubMed ID: 18631251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the IkappaB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells.
    Arsura M; Mercurio F; Oliver AL; Thorgeirsson SS; Sonenshein GE
    Mol Cell Biol; 2000 Aug; 20(15):5381-91. PubMed ID: 10891479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mode of action of liver tumor induction by trichloroethylene and its metabolites, trichloroacetate and dichloroacetate.
    Bull RJ
    Environ Health Perspect; 2000 May; 108 Suppl 2(Suppl 2):241-59. PubMed ID: 10807555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1.
    Aoki H; Hayashi J; Moriyama M; Arakawa Y; Hino O
    J Virol; 2000 Feb; 74(4):1736-41. PubMed ID: 10644344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAS and the myelodysplastic syndromes.
    Gallagher A; Darley R; Padua RA
    Pathol Biol (Paris); 1997 Sep; 45(7):561-8. PubMed ID: 9404480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ha-ras in normal and tumoral tissues: structure, function and regulation.
    Solanas M; Escrich E
    Rev Esp Fisiol; 1996 Sep; 52(3):173-92. PubMed ID: 8974153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential selection for B-raf and Ha-ras mutated liver tumors in mice with high and low susceptibility to hepatocarcinogenesis.
    Buchmann A; Karcier Z; Schmid B; Strathmann J; Schwarz M
    Mutat Res; 2008 Feb; 638(1-2):66-74. PubMed ID: 17928010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1.
    Bissonnette M; Khare S; von Lintig FC; Wali RK; Nguyen L; Zhang Y; Hart J; Skarosi S; Varki N; Boss GR; Brasitus TA
    Cancer Res; 2000 Aug; 60(16):4602-9. PubMed ID: 10969813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
    Goodrow T; Reynolds S; Maronpot R; Anderson M
    Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative transcriptome and proteome analysis of Ha-ras and B-raf mutated mouse liver tumors.
    Rignall B; Ittrich C; Krause E; Appel KE; Buchmann A; Schwarz M
    J Proteome Res; 2009 Aug; 8(8):3987-94. PubMed ID: 19476384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in GTPase-activating protein activity between liver tumors and normal liver tissue in mice.
    Müller O; Frech M; Gideon P; Wittinghofer A; Schwarz M
    Oncogene; 1992 Jul; 7(7):1407-12. PubMed ID: 1620552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p21Ras downstream effectors are increased in activity or expression in mouse liver tumors but do not differ between ras-mutated and ras-wild-type lesions.
    Kalkuhl A; Troppmair J; Buchmann A; Stinchcombe S; Buenemann CL; Rapp UR; Kaestner K; Schwarz M
    Hepatology; 1998 Apr; 27(4):1081-8. PubMed ID: 9537449
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.